Published in J Addict Med on September 01, 2008
Mindfulness-based relapse prevention for substance use disorders: a pilot efficacy trial. Subst Abus (2009) 2.83
Mindfulness-based treatments for co-occurring depression and substance use disorders: what can we learn from the brain? Addiction (2010) 2.50
Mindfulness meditation for substance use disorders: a systematic review. Subst Abus (2009) 1.75
Mindfulness training modifies cognitive, affective, and physiological mechanisms implicated in alcohol dependence: results of a randomized controlled pilot trial. J Psychoactive Drugs (2010) 1.71
Mindfulness training and stress reactivity in substance abuse: results from a randomized, controlled stage I pilot study. Subst Abus (2009) 1.62
Associations of mindfulness with nicotine dependence, withdrawal, and agency. Subst Abus (2009) 1.35
Craving to quit: psychological models and neurobiological mechanisms of mindfulness training as treatment for addictions. Psychol Addict Behav (2012) 1.22
Targeting cognitive-affective risk mechanisms in stress-precipitated alcohol dependence: an integrated, biopsychosocial model of automaticity, allostasis, and addiction. Med Hypotheses (2011) 1.13
Retraining the addicted brain: a review of hypothesized neurobiological mechanisms of mindfulness-based relapse prevention. Psychol Addict Behav (2012) 0.95
Mindfulness training for smoking cessation: moderation of the relationship between craving and cigarette use. Drug Alcohol Depend (2012) 0.94
Associations between mindfulness and implicit cognition and self-reported affect. Subst Abus (2009) 0.92
The Addict in Us all. Front Psychiatry (2014) 0.85
Treatment approaches for interoceptive dysfunctions in drug addiction. Front Psychiatry (2013) 0.83
Mindfulness as a strategy for coping with cue-elicited cravings for alcohol: an experimental examination. Alcohol Clin Exp Res (2014) 0.81
Pilot randomized trial on mindfulness training for smokers in young adult binge drinkers. BMC Complement Altern Med (2013) 0.80
Neural stress reactivity relates to smoking outcomes and differentiates between mindfulness and cognitive-behavioral treatments. Neuroimage (2016) 0.75
Mindfulness Meditation-Based Intervention Is Feasible, Acceptable, and Safe for Chronic Low Back Pain Requiring Long-Term Daily Opioid Therapy. J Altern Complement Med (2016) 0.75
Effectiveness of Mindfulness-Based Group Therapy Compared to the Usual Opioid Dependence Treatment. Iran J Psychiatry (2015) 0.75
Maintaining Treatment Fidelity of Mindfulness-Based Relapse Prevention Intervention for Alcohol Dependence: A Randomized Controlled Trial Experience. Evid Based Complement Alternat Med (2017) 0.75
A global measure of perceived stress. J Health Soc Behav (1983) 56.90
Combined pharmacotherapies and behavioral interventions for alcohol dependence: the COMBINE study: a randomized controlled trial. JAMA (2006) 13.15
The benefits of being present: mindfulness and its role in psychological well-being. J Pers Soc Psychol (2003) 12.05
The timeline followback reports of psychoactive substance use by drug-abusing patients: psychometric properties. J Consult Clin Psychol (2000) 7.71
An outpatient program in behavioral medicine for chronic pain patients based on the practice of mindfulness meditation: theoretical considerations and preliminary results. Gen Hosp Psychiatry (1982) 5.93
Mindfulness-based cognitive therapy for depression: replication and exploration of differential relapse prevention effects. J Consult Clin Psychol (2004) 4.40
Mindfulness-based stress reduction in relation to quality of life, mood, symptoms of stress, and immune parameters in breast and prostate cancer outpatients. Psychosom Med (2003) 2.75
Alcohol-related morbidity and mortality. Alcohol Res Health (2003) 2.57
How effective is alcoholism treatment in the United States? J Stud Alcohol (2001) 2.42
The Obsessive Compulsive Drinking Scale: a self-rated instrument for the quantification of thoughts about alcohol and drinking behavior. Alcohol Clin Exp Res (1995) 2.32
Cardiovascular disease, interleukin-6, and risk of mortality in older women: the women's health and aging study. Circulation (2001) 2.29
Three-year follow-up and clinical implications of a mindfulness meditation-based stress reduction intervention in the treatment of anxiety disorders. Gen Hosp Psychiatry (1995) 2.24
The obsessive compulsive drinking scale: A new method of assessing outcome in alcoholism treatment studies. Arch Gen Psychiatry (1996) 2.22
Mindfulness meditation and substance use in an incarcerated population. Psychol Addict Behav (2006) 2.12
Estimating the effect of help-seeking on achieving recovery from alcohol dependence. Addiction (2006) 1.87
Recent advances in alcoholic liver disease. IV. Dysregulated cytokine metabolism in alcoholic liver disease. Am J Physiol Gastrointest Liver Physiol (2004) 1.69
Matching alcoholism treatments to client heterogeneity: treatment main effects and matching effects on drinking during treatment. Project MATCH Research Group. J Stud Alcohol (1998) 1.61
A pilot study on mindfulness based stress reduction for smokers. BMC Complement Altern Med (2007) 1.55
Outcome predictors in substance use disorders. Psychiatr Clin North Am (2003) 1.48
Validity of the Obsessive Compulsive Drinking Scale (OCDS): does craving predict drinking behavior? Alcohol Clin Exp Res (1999) 1.27
Psychometric properties and validity of the obsessive-compulsive drinking scale. Alcohol Clin Exp Res (1996) 1.00
Influence of acute alcohol intake and alcohol withdrawal on circulating levels of IL-6, IL-8, IL-10 and IL-12. Cytokine (2000) 0.91
Meditation and alcohol use. South Med J (2007) 0.89
The use of a symptom checklist (SCL-90-R) as an easy method to estimate the relapse risk after alcoholism detoxification. Eur Addict Res (2002) 0.81
Design and implementation of microarray gene expression markup language (MAGE-ML). Genome Biol (2002) 16.75
Extended-release niacin or ezetimibe and carotid intima-media thickness. N Engl J Med (2009) 9.35
A simple spreadsheet-based, MIAME-supportive format for microarray data: MAGE-TAB. BMC Bioinformatics (2006) 7.53
Cognitive functioning of long-term heavy cannabis users seeking treatment. JAMA (2002) 6.48
Pattern separation in the human hippocampal CA3 and dentate gyrus. Science (2008) 5.56
Reduction of alcohol consumption by brief alcohol intervention in primary care: systematic review and meta-analysis. Arch Intern Med (2005) 5.03
A null mutation in human APOC3 confers a favorable plasma lipid profile and apparent cardioprotection. Science (2008) 4.50
The first RSBI (ISA-TAB) workshop: "can a simple format work for complex studies?". OMICS (2008) 4.15
The Functional Genomics Experiment model (FuGE): an extensible framework for standards in functional genomics. Nat Biotechnol (2007) 3.55
Direct care workers in the National Drug Abuse Treatment Clinical Trials Network: characteristics, opinions, and beliefs. Psychiatr Serv (2007) 3.38
Time of birth and risk of neonatal death at term: retrospective cohort study. BMJ (2010) 2.74
Intraocular concentration and pharmacokinetics of triamcinolone acetonide after a single intravitreal injection. Ophthalmology (2003) 2.61
Objective and subjective sleep quality in premenopausal, perimenopausal, and postmenopausal women in the Wisconsin Sleep Cohort Study. Sleep (2003) 2.60
Validity of the alcohol use disorders identification test in college students. Alcohol Clin Exp Res (2004) 2.30
A research mentor training curriculum for clinical and translational researchers. Clin Transl Sci (2012) 2.21
Loss of raltegravir susceptibility by human immunodeficiency virus type 1 is conferred via multiple nonoverlapping genetic pathways. J Virol (2009) 2.19
Strengthening the career development of clinical translational scientist trainees: a consensus statement of the Clinical Translational Science Award (CTSA) Research Education and Career Development Committees. Clin Transl Sci (2012) 2.18
Clinically validated genotype analysis: guiding principles and statistical concerns. Antivir Ther (2004) 2.14
Organizational Readiness for Change and opinions toward treatment innovations. J Subst Abuse Treat (2007) 2.14
Deriving competencies for mentors of clinical and translational scholars. Clin Transl Sci (2012) 2.12
Barriers to a cure for HIV: new ways to target and eradicate HIV-1 reservoirs. Lancet (2013) 2.11
Susceptibility to amoxicillin-clavulanate-induced liver injury is influenced by multiple HLA class I and II alleles. Gastroenterology (2011) 2.01
The Marijuana Treatment Project: rationale, design and participant characteristics. Addiction (2002) 1.94
Omega-3 fatty acids and coronary heart disease risk: clinical and mechanistic perspectives. Atherosclerosis (2007) 1.93
Mindfulness meditation for substance use disorders: a systematic review. Subst Abus (2009) 1.75
Image-based estimation of ventricular fiber orientations for personalized modeling of cardiac electrophysiology. IEEE Trans Med Imaging (2012) 1.72
Treatment programs in the National Drug Abuse Treatment Clinical Trials Network. Drug Alcohol Depend (2007) 1.64
A chloroplast transgenic approach to hyper-express and purify Human Serum Albumin, a protein highly susceptible to proteolytic degradation. Plant Biotechnol J (2003) 1.64
Familial defective apolipoprotein B-100 and increased low-density lipoprotein cholesterol and coronary artery calcification in the old order amish. Arch Intern Med (2010) 1.64
Pharmacodynamics of the type II calcimimetic compound cinacalcet HCl. J Pharmacol Exp Ther (2003) 1.63
Maternal cortisol levels and behavior problems in adolescents and adults with ASD. J Autism Dev Disord (2010) 1.63
Rising national prevalence of life-limiting conditions in children in England. Pediatrics (2012) 1.59
Identifying and aligning expectations in a mentoring relationship. Clin Transl Sci (2011) 1.58
Mentoring K scholars: strategies to support research mentors. Clin Transl Sci (2011) 1.57
Evaluating and giving feedback to mentors: new evidence-based approaches. Clin Transl Sci (2011) 1.55
Trisodium citrate 46.7% selectively and safely reduces staphylococcal catheter-related bacteraemia. Nephrol Dial Transplant (2008) 1.52
Themes of holism, empowerment, access, and legitimacy define complementary, alternative, and integrative medicine in relation to conventional biomedicine. J Altern Complement Med (2003) 1.51
High-density lipoproteins: a consensus statement from the National Lipid Association. J Clin Lipidol (2013) 1.50
ABCA1(Alabama): a novel variant associated with HDL deficiency and premature coronary artery disease. Atherosclerosis (2002) 1.49
Durable efficacy and safety of raltegravir versus efavirenz when combined with tenofovir/emtricitabine in treatment-naive HIV-1-infected patients: final 5-year results from STARTMRK. J Acquir Immune Defic Syndr (2013) 1.48
Role of LCAT in HDL remodeling: investigation of LCAT deficiency states. J Lipid Res (2006) 1.47
In vitro susceptibility of adefovir-associated hepatitis B virus polymerase mutations to other antiviral agents. Antivir Ther (2007) 1.46
Early impact of prescription Omega-3 fatty acids on platelet biomarkers in patients with coronary artery disease and hypertriglyceridemia. Cardiology (2011) 1.46
Nasal irrigation as adjunctive care for acute sinusitis. J Fam Pract (2004) 1.46
Patient satisfaction, prescription drug abuse, and potential unintended consequences. JAMA (2012) 1.45
The two novel CETP mutations Gln87X and Gln165X in a compound heterozygous state are associated with marked hyperalphalipoproteinemia and absence of significant coronary artery disease. J Mol Med (Berl) (2006) 1.42
Resistance to chronic wasting disease in transgenic mice expressing a naturally occurring allelic variant of deer prion protein. J Virol (2007) 1.41
FuGE: Functional Genomics Experiment Object Model. OMICS (2006) 1.39
How do emergency department patients store and dispose of opioids after discharge? A pilot study. J Emerg Nurs (2011) 1.38
The ARBITER 6-HALTS Trial (Arterial Biology for the Investigation of the Treatment Effects of Reducing Cholesterol 6-HDL and LDL Treatment Strategies in Atherosclerosis): final results and the impact of medication adherence, dose, and treatment duration. J Am Coll Cardiol (2010) 1.36
The Oak Ridge Polycystic Kidney mouse: modeling ciliopathies of mice and men. Dev Dyn (2008) 1.36
Selection of research mentors for K-funded scholars. Clin Transl Sci (2011) 1.35
Does glycemic variability impact mood and quality of life? Diabetes Technol Ther (2012) 1.35
Lead toxicity in a 14-year-old female with retained bullet fragments. Pediatrics (2006) 1.34
A novel assay allows genotyping of the latent reservoir for human immunodeficiency virus type 1 in the resting CD4+ T cells of viremic patients. J Virol (2005) 1.32
Chromosomal location plays a role in regulation of aflatoxin gene expression in Aspergillus parasiticus. Appl Environ Microbiol (2002) 1.31
Placebo, meaning, and health. Perspect Biol Med (2006) 1.31
Hepatitis B virus genotypes and virologic response in 694 patients in phase III studies of adefovir dipivoxil1. Gastroenterology (2003) 1.31
Analysis of the HIV-1 gp41 specific immune response using a multiplexed antibody detection assay. J Immunol Methods (2004) 1.29
Hypertriglyceridemia and cardiovascular risk reduction. Clin Ther (2007) 1.28
Annotare--a tool for annotating high-throughput biomedical investigations and resulting data. Bioinformatics (2010) 1.26
Cross-resistance testing of next-generation nucleoside and nucleotide analogues against lamivudine-resistant HBV. Antivir Ther (2005) 1.25
Brief strategic family therapy versus treatment as usual: results of a multisite randomized trial for substance using adolescents. J Consult Clin Psychol (2011) 1.23
The effect of delaying childbirth on primary cesarean section rates. PLoS Med (2008) 1.22
Differential sensitivity to life stress in FMR1 premutation carrier mothers of children with fragile X syndrome. Health Psychol (2011) 1.21
Estimating the client costs of addiction treatment: first findings from the client drug abuse treatment cost analysis program (Client DATCAP). Drug Alcohol Depend (2003) 1.19
Long-term user perceptions of an implanted neuroprosthesis for exercise, standing, and transfers after spinal cord injury. J Rehabil Res Dev (2003) 1.19
Rationale and methods for a trial assessing placebo, echinacea, and doctor-patient interaction in the common cold. Explore (NY) (2007) 1.18
Ethyl glucuronide: a biomarker to identify alcohol use by health professionals recovering from substance use disorders. Alcohol Alcohol (2004) 1.17
The use of social-networking sites in medical education. Med Teach (2013) 1.16
A randomised controlled 8-week crossover clinical evaluation of the 3M Coban 2 Layer Compression System versus Profore to evaluate the product performance in patients with venous leg ulcers. Int Wound J (2008) 1.15
Bath salts as a "legal high". Am J Med (2011) 1.15
Balloon sinuplasty: a minimally invasive option for patients with chronic rhinosinusitis. Postgrad Med (2011) 1.15
Genotypic determinants of the virological response to tenofovir disoproxil fumarate in nucleoside reverse transcriptase inhibitor-experienced patients. Antivir Ther (2004) 1.14
Effect of dalcetrapib plus pravastatin on lipoprotein metabolism and high-density lipoprotein composition and function in dyslipidemic patients: results of a phase IIb dose-ranging study. Am Heart J (2012) 1.12
Tailoring cannabis dependence treatment for a diverse population. Addiction (2002) 1.12
Rates of and factors associated with delivery-related perinatal death among term infants in Scotland. JAMA (2009) 1.11
Progressive resistance training after stroke: effects on muscle strength, muscle tone, gait performance and perceived participation. J Rehabil Med (2008) 1.11
Depression and suicide ideation among students accessing campus health care. Am J Orthopsychiatry (2011) 1.11
Effectiveness of brief interventions after alcohol-related vehicular injury: A randomized controlled trial. J Trauma (2006) 1.10
Severe neurotoxicity following ingestion of tetraethyl lead. J Med Toxicol (2010) 1.08
Methadone maintenance and male sexual dysfunction. J Addict Dis (2005) 1.07
Comparison pharmacokinetics of two concentrations (0.7% and 1.0%) of Nasulin, an ultra-rapid-acting intranasal insulin formulation. J Diabetes Sci Technol (2010) 1.07
Infection surveillance and control programs in the Department of Veterans Affairs nursing home care units: a preliminary assessment. Am J Infect Control (2006) 1.07
Acculturation and cigarette smoking among pregnant Hispanic women residing in the United States. Am J Public Health (2007) 1.05
Placebo effects and the common cold: a randomized controlled trial. Ann Fam Med (2011) 1.05
Development of a replicon-based phenotypic assay for assessing the drug susceptibilities of HCV NS3 protease genes from clinical isolates. Antiviral Res (2008) 1.04
Prevalence of nursing home-associated infections in the Department of Veterans Affairs nursing home care units. Am J Infect Control (2008) 1.04
Validation of endoscopic activity scores in patients with Crohn's disease based on a post hoc analysis of data from SONIC. Gastroenterology (2013) 1.03
Research pointers: Platelet responsiveness to aspirin in patients with hyperlipidaemia. BMJ (2003) 1.03
Adverse effects and cognitive function among primary care patients taking opioids for chronic nonmalignant pain. J Opioid Manag (2007) 1.02
Disulfide-linked antibody-maytansinoid conjugates: optimization of in vivo activity by varying the steric hindrance at carbon atoms adjacent to the disulfide linkage. Bioconjug Chem (2011) 1.01
Videoconferencing for practice-based small-group continuing medical education: feasibility, acceptability, effectiveness, and cost. J Contin Educ Health Prof (2003) 1.00
Pharmacokinetic and pharmacodynamic interactions of oral midazolam with ketoconazole, fluoxetine, fluvoxamine, and nefazodone. J Clin Pharmacol (2003) 0.99
Oral tocotrienols are transported to human tissues and delay the progression of the model for end-stage liver disease score in patients. J Nutr (2012) 0.99
"Nurse, I only had a couple of beers": validity of self-reported drinking before serious vehicular injury. Am J Crit Care (2002) 0.98
Baseline disease activity, hyperlipidemia, and hypertension are predictive factors for ischemic stroke and stroke severity in systemic lupus erythematosus. Stroke (2007) 0.97